Last updated on July 2020

Study of the Efficacy of Early Intervention With Secukinumab 300 mg s.c. Compared to Narrow-band UVB in Patients With New-onset Moderate to Severe Plaque Psoriasis

Find a site near you

Start Over

Novartis Investigative Site

Ciudad Autonoma de Bs As, Argentina
  Connect »

Novartis Investigative Site

Las Palmas de Gran Canaria, Spain
  Connect »

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.